Phase II Pilot Study of TPF (Docetaxel, Cisplatin, and 5-FU) Induction Chemotherapy Followed by Concurrent Cisplatin and Reduced Dose Radiation in Locally Advanced Head and Neck Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Docetaxel; Fluorouracil
- Indications Head and neck cancer
- Focus Therapeutic Use
- 28 Dec 2017 Biomarkers information updated
- 28 Jul 2009 Actual patient number (4) added as reported by ClinicalTrials.gov.
- 28 Jul 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.